Bengaluru, Nov. 14 -- Known for developing and manufacturing complex pharmaceutical formulations, the company delivered strong quarterly results with solid revenue and profit growth. Investors reacted positively as the stock surged after it reported a 56% year-on-year profit jump, signaling improving operational performance and robust demand momentum.

Rubicon Research Limited's stock, with a market capitalisation of Rs. 11,218 crores, rose to Rs. 725.95, hitting a high of up to 10.94 percent from its previous closing price of Rs. 654.35. Furthermore, the stock over the past year has given a return of 8.52 percent.

Company Growth Story

This company started in 1999 by providing basic contract development services. Back then, it mainly wo...